• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的历史。

History of Nonalcoholic Fatty Liver Disease.

机构信息

Ospedale Civile di Baggiovara, UOC Medicina Metabolica, Dipartimento di Medicina Interna Generale, d'Urgenza e post Acuzie, Azienda Ospedaliero-Universitaria di Modena, Via Giardini 1135, 41125 Modena, Italy.

Internal Medicine Unit, Department of Digestive Diseases, S.Orsola-Malpighi Hospital, Via Massarenti 9, 40136 Bologna, Italy.

出版信息

Int J Mol Sci. 2020 Aug 16;21(16):5888. doi: 10.3390/ijms21165888.

DOI:10.3390/ijms21165888
PMID:32824337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7460697/
Abstract

Based on the assumption that characterizing the history of a disease will help in improving practice while offering a clue to research, this article aims at reviewing the history of nonalcoholic fatty liver disease (NAFLD) in adults and children. To this end, we address the history of NAFLD histopathology, which begins in 1980 with Ludwig's seminal studies, although previous studies date back to the 19th century. Moreover, the principal milestones in the definition of genetic NAFLD are summarized. Next, a specific account is given of the evolution, over time, of our understanding of the association of NAFLD with metabolic syndrome, spanning from the outdated concept of , to the more appropriate consideration that NAFLD has, with metabolic syndrome, a mutual and bi-directional relationship. In addition, we also report on the evolution from first intuitions to more recent studies, supporting NAFLD as an independent risk factor for cardiovascular disease. This association probably has deep roots, going back to ancient Middle Eastern cultures, wherein the liver had a significance similar to that which the heart holds in contemporary society. Conversely, the notions that NAFLD is a forerunner of hepatocellular carcinoma and extra-hepatic cancers is definitely more modern. Interestingly, guidelines issued by hepatological societies have lagged behind the identification of NAFLD by decades. A comparative analysis of these documents defines both shared attitudes (e.g., ultrasonography and lifestyle changes as the first approaches) and diverging key points (e.g., the threshold of alcohol consumption, screening methods, optimal non-invasive assessment of liver fibrosis and drug treatment options). Finally, the principal historical steps in the general, cellular and molecular pathogenesis of NAFLD are reviewed. We conclude that an in-depth understanding of the history of the disease permits us to better comprehend the disease itself, as well as to anticipate the lines of development of future NAFLD research.

摘要

基于这样一种假设,即描述疾病的历史有助于改进实践并为研究提供线索,本文旨在回顾成人和儿童非酒精性脂肪性肝病(NAFLD)的历史。为此,我们探讨了 NAFLD 组织病理学的历史,该历史始于 1980 年 Ludwig 的开创性研究,尽管之前的研究可以追溯到 19 世纪。此外,总结了遗传 NAFLD 定义的主要里程碑。接下来,具体描述了我们对 NAFLD 与代谢综合征之间关联的认识随时间的演变,从过时的概念到更合适的考虑,即 NAFLD 与代谢综合征之间存在相互的双向关系。此外,我们还报告了从最初的直觉到最近的研究的演变,支持 NAFLD 作为心血管疾病的独立危险因素。这种关联可能有很深的根源,可以追溯到古代中东文化,在当时肝脏的重要性与当今社会中心脏的重要性相似。相反,NAFLD 是肝细胞癌和肝外癌症的前兆的概念则是更为现代的。有趣的是,几十年后,肝脏病学会才发布了与 NAFLD 相关的指南。对这些文件的比较分析定义了共同的态度(例如,超声检查和生活方式改变是最初的方法)和分歧的关键点(例如,酒精摄入量的阈值,筛查方法,肝纤维化的最佳非侵入性评估和药物治疗选择)。最后,回顾了 NAFLD 一般、细胞和分子发病机制的主要历史步骤。我们的结论是,深入了解疾病的历史可以帮助我们更好地理解疾病本身,并预测未来 NAFLD 研究的发展方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0971/7460697/1ce09813887b/ijms-21-05888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0971/7460697/1ce09813887b/ijms-21-05888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0971/7460697/1ce09813887b/ijms-21-05888-g001.jpg

相似文献

1
History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的历史。
Int J Mol Sci. 2020 Aug 16;21(16):5888. doi: 10.3390/ijms21165888.
2
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:非酒精性脂肪性肝病患者肝细胞癌的筛查和监测:专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
3
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.2020 年非酒精性脂肪性肝病/非酒精性脂肪性肝炎临床实践循证指南。
J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17.
4
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.当前非酒精性脂肪性肝病管理指南:系统评价与比较分析。
World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.
5
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
6
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:通过饮食和运动来实现减肥以治疗非酒精性脂肪性肝病的生活方式干预:专家综述。
Gastroenterology. 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9.
7
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
8
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management.精准医学方法在非酒精性脂肪性肝病诊断和管理中的应用展望。
Adv Ther. 2021 May;38(5):2130-2158. doi: 10.1007/s12325-021-01690-1. Epub 2021 Apr 7.
9
Nonalcoholic fatty liver disease: Evolving paradigms.非酒精性脂肪性肝病:不断变化的范式。
World J Gastroenterol. 2017 Sep 28;23(36):6571-6592. doi: 10.3748/wjg.v23.i36.6571.
10
Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.从19世纪的脂肪肝到当代非酒精性脂肪性肝病的历史叙事——调和过去与现在。
JHEP Rep. 2021 Feb 26;3(3):100261. doi: 10.1016/j.jhepr.2021.100261. eCollection 2021 Jun.

引用本文的文献

1
Evolving etiologies of liver transplantation: a trend analysis from 2020 to 2024 at the main center of Iran.肝移植病因的演变:2020年至2024年伊朗主要中心的趋势分析
Gastroenterol Hepatol Bed Bench. 2025;18(1):115-119. doi: 10.22037/ghfbb.v18i1.3035.
2
Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.健康与疾病中的核受体:信号通路、生物学功能及药物干预
Signal Transduct Target Ther. 2025 Jul 28;10(1):228. doi: 10.1038/s41392-025-02270-3.
3
Cultural and Molecular Factors Predisposed to Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

本文引用的文献

1
The metabolic basis of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的代谢基础
Endocrinol Diabetes Metab. 2020 Feb 24;3(4):e00112. doi: 10.1002/edm2.112. eCollection 2020 Oct.
2
The "obese liver" and gastrointestinal cancer risk.“肥胖肝脏”与胃肠道癌症风险
Transl Gastroenterol Hepatol. 2020 Jul 5;5:44. doi: 10.21037/tgh.2019.12.07. eCollection 2020.
3
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.肝活检评估的可靠性欠佳对随机临床试验有影响。
易患非酒精性脂肪性肝病和2型糖尿病的文化及分子因素。
Nutrients. 2025 May 26;17(11):1797. doi: 10.3390/nu17111797.
4
Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study.非酒精性脂肪性肝炎与肝脂肪变性及肝纤维化之间的关联:一项基于人群的研究。
Sci Rep. 2025 Mar 12;15(1):8462. doi: 10.1038/s41598-025-90818-2.
5
MASLD, MLA Pesarattu and Other Developments.代谢功能障碍相关脂肪性肝病、MLA佩萨拉图及其他进展
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102465. doi: 10.1016/j.jceh.2024.102465. Epub 2024 Nov 22.
6
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics.从下丘脑性肥胖到代谢功能障碍相关脂肪性肝病:生理学通过代谢组学与临床相遇。
Metabolites. 2024 Jul 26;14(8):408. doi: 10.3390/metabo14080408.
7
Epidemiology of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
8
Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease.网络药理学和分子对接结合分子动力学模拟研究茵陈蒿汤治疗非酒精性脂肪性肝病的药理机制
Curr Comput Aided Drug Des. 2024 Jul 11. doi: 10.2174/0115734099305489240702075128.
9
Usefulness of Neck Circumference, Waist-to-Height Ratio and Waist-to-Hip Ratio in Predicting Non-Alcoholic Fatty Liver Disease in Saudi Population Without Type 2 Diabetes.颈围、腰高比和腰臀比在预测无2型糖尿病的沙特人群非酒精性脂肪性肝病中的效用
Nutr Metab Insights. 2024 Jun 22;17:11786388241259942. doi: 10.1177/11786388241259942. eCollection 2024.
10
Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.微生物群和免疫系统在代谢功能障碍相关脂肪性肝病发生和进展中的作用。
Nutrients. 2024 May 29;16(11):1668. doi: 10.3390/nu16111668.
J Hepatol. 2020 Dec;73(6):1322-1332. doi: 10.1016/j.jhep.2020.06.025. Epub 2020 Jun 28.
4
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:术语过早改变的影响。
Hepatology. 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6.
5
Comparison of MAFLD and NAFLD diagnostic criteria in real world.现实世界中MAFLD与NAFLD诊断标准的比较。
Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.
6
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease.代谢相关脂肪性肝病的表观遗传药物发现全景。
Trends Genet. 2020 Jun;36(6):429-441. doi: 10.1016/j.tig.2020.03.003. Epub 2020 Mar 28.
7
What's in a name? Renaming 'NAFLD' to 'MAFLD'.名字里有什么?将“非酒精性脂肪性肝病”重新命名为“代谢功能障碍相关脂肪性肝病” 。 (备注:MAFLD全称为Metabolic Dysfunction-Associated Fatty Liver Disease ,直译为代谢功能障碍相关脂肪性肝病 ,是对NAFLD(Non-alcoholic Fatty Liver Disease,非酒精性脂肪性肝病)的重新命名 。这里如果仅按字面意思翻译,可能不太能理解其背景含义,补充了备注供你参考。)
Liver Int. 2020 Jun;40(6):1254-1261. doi: 10.1111/liv.14478. Epub 2020 Apr 28.
8
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
9
Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.非酒精性脂肪性肝病/酒精性肝病中外泌体:从病理生物学到治疗。
Cells. 2020 Mar 27;9(4):817. doi: 10.3390/cells9040817.
10
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎:综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.